Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo ...
healthday1h
Cardiovascular Risk and Obesity Affect Brain Volume in Middle Age
The strongest influence of cardiovascular risk and obesity on reduced brain volume is seen between 55 and 64 years o ...
Porridge and crumpets included in new junk food ad ban
Certain types of porridge, crumpets and breakfast cereals are included in a list of products that fall under a new junk food ...
Why Is Scholar Rock Holding Corporation (SRRK) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds. In this ...
healthday1h
RSNA: Obesity, VAT Linked to Measures of Amyloid Burden in Midlife
Obesity and visceral fat are associated with measures of amyloid burden in the brain among cognitively normal midlif ...
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?
W ith more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...
TCTMD2h
Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Topline Results
Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.
Wall Street Lunch: UnitedHealthcare Executive Gunned Down In New York
UnitedHealthcare CEO Brian Thompson was shot outside a Manhattan hotel, with the attack appearing targeted; the assailant ...
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, ...
btimesonline2h
Zepbound Delivers 47% Greater Weight Loss Than Wegovy, Eli Lilly Claims
Eli Lilly's Zepbound has outperformed Novo Nordisk's Wegovy in a pivotal clinical trial, marking a significant milestone in ...
14% Of Spine Surgeries Deemed Unnecessary. Could RFK Jr. Change That?
Kennedy Jr. speaks with President-elect Donald Trump. RFK Jr. ... [+] has pledged to Make America Healthy Again (Photo by ...
Eli Lilly says Zepbound's weight-loss results beat those of rival Wegovy
Eli Lilly & Co. Inc.'s stock (LLY) rose 2.3% Wednesday, after the company said its Zepbound weight-loss drug was more effective than rival Novo Nordisk's Wegovy in a head-to-head study.